Recruiting
Phase 1
Phase 2

AMXT 1501 & DFMO

Sponsor:

Milton S. Hershey Medical Center

Code:

NCT06465199

Conditions

Atypical Teratoid/Rhabdoid Tumor

Neuroblastoma Recurrent

Embryonal Tumor With Multilayered Rosettes

DIPG Brain Tumor

Ewing Sarcoma

Eligibility Criteria

Sex: All

Age: 0 - 21

Healthy Volunteers: Not accepted

Interventions

Eflornithine (DFMO)

AMXT 1501 Dicaprate

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-31. This information was provided to ClinicalTrials.gov by Milton S. Hershey Medical Center on 2025-10-20.